Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × ENT Cancer × Escitalopram × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Depression 4 Polycystic Ovary Syndrome 2 Depressive Disorder, Major 2 Neoplasms 1 Lymphoma, Follicular 1 Hot Flashes 1 Head and Neck Neoplasms 1 ENT Cancer 1 Breast Neoplasms 1 Asthma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02246244 2016-06-10

TADDOR

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed

ENT Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡